European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3

Standard

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3. / Panzuto, Francesco; Ramage, John; Pritchard, D Mark; van Velthuysen, Marie-Louise F; Schrader, Joerg; Begum, Nehara; Sundin, Anders; Falconi, Massimo; O'Toole, Dermot.

In: J NEUROENDOCRINOL, Vol. 35, No. 8, 08.2023, p. e13306.

Research output: SCORING: Contribution to journalGuideline, recommendation, statementResearchpeer-review

Harvard

Panzuto, F, Ramage, J, Pritchard, DM, van Velthuysen, M-LF, Schrader, J, Begum, N, Sundin, A, Falconi, M & O'Toole, D 2023, 'European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3', J NEUROENDOCRINOL, vol. 35, no. 8, pp. e13306. https://doi.org/10.1111/jne.13306

APA

Panzuto, F., Ramage, J., Pritchard, D. M., van Velthuysen, M-L. F., Schrader, J., Begum, N., Sundin, A., Falconi, M., & O'Toole, D. (2023). European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3. J NEUROENDOCRINOL, 35(8), e13306. https://doi.org/10.1111/jne.13306

Vancouver

Bibtex

@article{3b26fbe8cde64de4b93ab19ef78b76a1,
title = "European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3",
abstract = "The aim of the present guidance paper was to update the previous ENETS guidelines on well-differentiated gastric and duodenal neuroendocrine tumours (NETs), providing practical guidance for specialists in the diagnosis and management of gastroduodenal NETs. Type II gastric NETs, neuroendocrine carcinomas (NECs), and functioning duodenal NETs are not covered, since they will be discussed in other ENETS guidance papers.",
keywords = "Humans, Neuroendocrine Tumors/diagnosis, Stomach Neoplasms/diagnosis, Societies, Carcinoma, Neuroendocrine",
author = "Francesco Panzuto and John Ramage and Pritchard, {D Mark} and {van Velthuysen}, {Marie-Louise F} and Joerg Schrader and Nehara Begum and Anders Sundin and Massimo Falconi and Dermot O'Toole",
note = "{\textcopyright} 2023 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.",
year = "2023",
month = aug,
doi = "10.1111/jne.13306",
language = "English",
volume = "35",
pages = "e13306",
journal = "J NEUROENDOCRINOL",
issn = "0953-8194",
publisher = "Wiley-Blackwell",
number = "8",

}

RIS

TY - JOUR

T1 - European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3

AU - Panzuto, Francesco

AU - Ramage, John

AU - Pritchard, D Mark

AU - van Velthuysen, Marie-Louise F

AU - Schrader, Joerg

AU - Begum, Nehara

AU - Sundin, Anders

AU - Falconi, Massimo

AU - O'Toole, Dermot

N1 - © 2023 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.

PY - 2023/8

Y1 - 2023/8

N2 - The aim of the present guidance paper was to update the previous ENETS guidelines on well-differentiated gastric and duodenal neuroendocrine tumours (NETs), providing practical guidance for specialists in the diagnosis and management of gastroduodenal NETs. Type II gastric NETs, neuroendocrine carcinomas (NECs), and functioning duodenal NETs are not covered, since they will be discussed in other ENETS guidance papers.

AB - The aim of the present guidance paper was to update the previous ENETS guidelines on well-differentiated gastric and duodenal neuroendocrine tumours (NETs), providing practical guidance for specialists in the diagnosis and management of gastroduodenal NETs. Type II gastric NETs, neuroendocrine carcinomas (NECs), and functioning duodenal NETs are not covered, since they will be discussed in other ENETS guidance papers.

KW - Humans

KW - Neuroendocrine Tumors/diagnosis

KW - Stomach Neoplasms/diagnosis

KW - Societies

KW - Carcinoma, Neuroendocrine

U2 - 10.1111/jne.13306

DO - 10.1111/jne.13306

M3 - Guideline, recommendation, statement

C2 - 37401795

VL - 35

SP - e13306

JO - J NEUROENDOCRINOL

JF - J NEUROENDOCRINOL

SN - 0953-8194

IS - 8

ER -